Fu Jen Catholic University
16 imported, source-linked research records. Open-access records.
16 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Fu Jen Catholic University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–16 of 16 matching records. Counts update as records arrive.
Association of preoperative sodium-glucose cotransporter 2 (SGLT2) inhibitor use with postoperative delirium and long-term cognitive decline in older adults: a target trial emulation
August 20, 2026 · 0 citations · Open access
Open original record →Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline
January 15, 2026 · 1 citations · Open access
Open original record →SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes
July 17, 2025 · 3 citations · Open access
Open original record →Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study
June 26, 2025 · 5 citations · Open access
Open original record →Adverse kidney events with initiation of SGLT2 inhibitors versus DPP4 inhibitors in diabetic people with a history of acute kidney injury
June 2, 2025 · 0 citations · Open access
Open original record →Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study
April 21, 2025 · 4 citations · Open access
Open original record →Correction to: Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation
March 15, 2025 · 0 citations · Open access
Open original record →Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis
January 23, 2025 · 23 citations · Open access
Open original record →Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation
January 22, 2025 · 4 citations · Open access
Open original record →Early reduction in albuminuria is associated with a steeper ‘dip’ in initial estimated glomerular filtration rate but favourable long‐term kidney outcomes in people with diabetes receiving sodium‐glucose cotransporter‐2 inhibitors
July 1, 2024 · 4 citations · Open access
Open original record →Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level
April 30, 2024 · 5 citations · Open access
Open original record →The use of sodium-glucose cotransporter 2 inhibitors and the incidence of uveitis in type 2 diabetes: a population-based cohort study
February 26, 2024 · 5 citations · Open access
Open original record →The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 Inhibitor
March 31, 2023 · 6 citations · Open access
Open original record →Pyuria Is Associated with Dysbiosis of the Urinary Microbiota in Type 2 Diabetes Patients Receiving Sodium–Glucose Cotransporter 2 Inhibitors
December 27, 2022 · 4 citations · Open access
Open original record →The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
November 6, 2020 · 68 citations · Open access
Open original record →Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection
October 22, 2020 · 101 citations · Open access
Open original record →